Efficacy of intravenous ibandronate injections in postmenopausal osteoporosis: 1-year findings from DIVA.

被引：0
|
作者：
Bolognese, M
Reid, DM
Langdahl, B
Hughes, C
Ward, P
Masanauskaite, D
Olszynski, WP
机构：
[1] Bethesda Hlth Res, Bethesda, MD USA
[2] Univ Aberdeen, Aberdeen, Scotland
[3] Arhus Amtssygehus, Aarhus, Denmark
[4] F Hoffmann La Roche Ltd, Basel, Switzerland
[5] Midtown Med Ctr, Saskatoon, SK, Canada
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [1] Renal safety of intravenous ibandronate injections in postmenopausal osteoporosis (PMO): DIVA 1-year results
    Civitelli, R
    Emkey, R
    Bolognese, M
    Recker, R
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 795 - 795
  • [2] Favorable renal safety profile of intravenous ibandronate injections in postmenopausal osteoporosis: 1-year results from DIVA
    Delmas, P
    Reid, D
    Felsenberg, D
    Leigh, C
    Ward, P
    Sedarati, F
    Christiansen, C
    BONE, 2005, 36 : S419 - S420
  • [3] Intravenous ibandronate injections are at least as effective and similarly well tolerated as daily oral ibandronate in postmenopausal osteoporosis: 1-year results from DIVA
    Adami, S
    Nuti, R
    Czerwinski, E
    Hughes, C
    Ward, P
    Bonvoisin, B
    Tanko, LB
    BONE, 2005, 36 : S137 - S138
  • [4] Favourable renal safety and tolerability profile of intravenous ibandronate injections in women with postmenopausal osteoporosis: 1-year results from diva
    Reid, DM
    Felsenberg, D
    Christiansen, C
    Leigh, C
    Ward, P
    Sedarati, F
    Delmas, PD
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 365 - 365
  • [5] Efficacy and Tolerability of Intravenous Ibandronate Injections in Postmenopausal Osteoporosis: 2-Year Results from the DIVA Study
    Mikosch, P.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (03): : 159 - +
  • [6] Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study
    Eisman, John A.
    Civitelli, Roberto
    Adaml, Silvano
    Czerwinski, Edward
    Recknor, Chris
    Prince, Richard
    Reginster, Jean-Yves
    Zaidi, Mone
    Felsenberg, Dieter
    Hughes, Claire
    Mairon, Nicole
    Masanauskaite, Daiva
    Reid, David M.
    Delmas, Pierre D.
    Recker, Robert R.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 488 - 497
  • [7] Consistent efficacy with intermittent intravenous ibandronate injections in postmenopausal osteoporosis: Diva 2-year analysis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S160 - S160
  • [8] Two-year efficacy and tolerability of intermittent intravenous ibandronate injections in postmenopausal osteoporosis: the DIVA study.
    Emkey, R
    Zaidi, V
    Lewiecki, EM
    Burdeska, A
    Mairon, N
    Rowell, L
    Eisman, JA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4060 - 4060
  • [9] Intermittent intravenous ibandronate injection regimens provide at least equivalent efficacy to daily oral ibandronate: 1-year results front DIVA.
    Recker, RR
    Reid, DM
    Sambrook, P
    Hughes, C
    Ward, P
    Bonvoisin, B
    Adami, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4095 - 4096
  • [10] Safety and tolerability of intravenous ibandronate injections: DIVA 1-year analysis.
    Drezner, MK
    Ste-Marie, LG
    Nuti, R
    Benhamou, C
    Leigh, C
    Ward, P
    Masanauskaite, D
    Lewiecki, EM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S396 - S396
12345